natgillin/translations-raw huggingface dataset:
It is appropriate to allow for the transfer of quota between undertakings listed in the Annex to increase the flexibility for undertakings to respond to changing market needs.
Ustrezno je dovoliti prenos kvote med podjetji iz Priloge, da se poveča prožnost podjetij pri prilagoditvi na spremenljive potrebe trga.
The quota should, however, cease with the decommissioning of the installation for which it was granted.
Vendar bi se kvota morala ukiniti ob razgradnji obrata, za katerega je bila dodeljena.
The undertaking should therefore notify the decommissioning of installations concerned to the Commission and the Member State concerned.
Podjetje mora zato Komisijo in zadevne države članice uradno obvestiti o razgradnji zadevnih obratov.
‘Make-up’ means the total quantity of a controlled substance in metric tonnes, whether virgin, recovered or reclaimed, that has not been used in the process cycle before and that is fed newly into the process cycle.
„Dopolnilo kvote“ pomeni skupno količino nadzorovane snovi v metričnih tonah, čiste, zajete ali predelane, ki prej ni bila uporabljena v proizvodnem ciklu in je vanj na novo uvedena.
‘Emission’ means the total quantity of a controlled substance in metric tonnes released into the atmosphere, water or soil during the process agent use and related storage and handling on the site of the installation.
„Emisija“ pomeni skupno količino nadzorovane snovi v metričnih tonah, ki se med uporabo predelovalnega sredstva sprosti v ozračje, vodo ali tla, ter z njo povezano skladiščenje in ravnanje na območju obrata.
Permitted process agent uses and threshold for emissions and quantities
Dovoljena predelovalna sredstva ter mejne vrednosti za emisije in količine
The Annex to this Decision establishes the list of undertakings for which the use of controlled substance as process agents shall be permitted as of 1 January 2010.
Priloga k temu sklepu določa seznam podjetij, v katerih se od 1. januarja 2010 dovoli uporaba nadzorovanih snovi kot predelovalnih sredstev.
Each undertaking shall only use the substance and the process set out in the Annex.
Vsako podjetje uporabi le snov in postopek, določena v Prilogi.
The quantities, set out in the Annex, that may be used annually as make-up and that may be emitted annually by each undertaking shall not be exceeded.
Količine, določene v Prilogi, ki se lahko letno uporabijo kot dopolnilo in jih podjetja lahko letno sprostijo, se ne presežejo.
The allocated quota shall loose its validity at the end of the year in which the installation for which the quota was granted is definitely decommissioned.
Dodelitev kvot postane neveljavna ob koncu leta, v katerem je obrat, za katerega je bila kvota odobrena, dokončno razgrajen.
Transfer of allocated quota
Prenos dodeljene kvote
An undertaking may fully or partially transfer its make-up quota allocated for an existing installation outlined in the Annex, regardless of the substance or use the quantity was allocated for, to another undertaking listed in the Annex.
Podjetje lahko v celoti ali delno svoje dopolnilo kvote, dodeljene za obstoječ obrat iz Priloge, ne glede na snov ali uporabo, za katero je bila dodeljena, prenese na drugo podjetje iz Priloge.
The beneficiary may use the quantity transferred for the substance and use allocated to the beneficiary in the Annex.
Prejemnik lahko preneseno količino uporabi za snov ali uporabo, ki je prejemniku dodeljena v Prilogi.
The transfer shall only take effect after its notification to the Commission and the competent authorities of the Member States concerned and confirmation from the Commission of its receipt.
Prenos začne veljati šele, ko so o tem uradno obveščeni Komisija in pristojni organi zadevnih držav članic in Komisija potrdi prejem uradnega obvestila.
Notification of decommissioning
Uradno obvestilo o razgradnji
In case of decommissioning of the installations concerned, undertakings listed in the Annex shall, within three month, notify the Commission and the competent authority of the Member State in which the installation was located thereof.
V primeru razgradnje zadevnega obrata podjetja iz Priloge v treh mesecih o tem uradno obvestijo Komisijo in pristojni organ zadevne države članice, v kateri je bil obrat nameščen.
(This Annex is not published because it contains confidential commercial information.)
[Ta priloga se ne objavi, ker vsebuje zaupne poslovne informacije.]
The allocation of the make-up quota should be based on the average needs in the years 2005 to 2008.
Dodelitev dopolnilne kvote bi morala temeljiti na podlagi povprečnih potreb v letih 2005 do 2008.
The calculation of the individual average demand should not consider years during which the respective undertaking did not use controlled substances as process agent.
V izračunu posameznega povprečnega povpraševanja ne bi smela biti zajeta leta, v katerih zadevno podjetje ni uporabljalo nadzorovanih snovi kot predelovalnih sredstev.
(notified under document C(2010) 4385)
(notificirano pod dokumentarno številko C(2010) 4385)
Having regard to Regulation (EC) No 223/2009 of the European Parliament and of the Council of 11 March 2009 on European statistics [1] and in particular Article 23 thereof,
ob upoštevanju Uredbe (ES) št. 223/2009 Evropskega parlamenta in Sveta z dne 11. marca 2009 o evropski statistiki [1] in zlasti člena 23 Uredbe,
Commission Regulation (EC) No 831/2002 of 17 May 2002 implementing Council Regulation (EC) No 322/97 on Community Statistics, concerning access to confidential data for scientific purposes [2] establishes, for the purpose of enabling statistical conclusions to be drawn for scientific purposes, the conditions under which access to confidential data transmitted to the Community authority may be granted and the rules of cooperation between the Community and national authorities in order to facilitate such access.
Uredba Komisije (ES) št. 831/2002 z dne 17. maja 2002 o izvajanju Uredbe Sveta (ES) št. 322/97 o statističnih podatkih Skupnosti glede dostopa do zaupnih podatkov v znanstvene namene [2] vzpostavlja pogoje, pod katerimi bi bilo mogoče odobriti dostop do zaupnih podatkov, poslanih organu Skupnosti, in pravila sodelovanja med Skupnostjo in državnimi organi za olajšanje takega dostopa.
Sabanci University, Tuzla/Istanbul, Turkey, McGill University, Montreal, Canada and Directorate Economic Service and Structural Reforms, Directorate General for Economic and Financial Affairs of the European Commission have to be regarded as bodies fulfilling the required conditions and should therefore be added to the list of agencies, organisations and institutions referred to in Article 3(1)(e) of Regulation (EC) No 831/2002.
Univerzi Sabanci University, Tuzla/Istanbul, Turčija in McGill University, Montreal, Kanada ter direktorat gospodarska služba in strukturne reforme Generalnega direktorata Evropske komisije za gospodarske in finančne zadeve je treba obravnavati kot organe, ki izpolnjujejo zahtevane pogoje, in jih je zato treba dodati na seznam agencij, organizacij in institucij iz člena 3(1)(e) Uredbe (ES) št. 831/2002.
The measures provided for in this Decision are in accordance with the opinion of the European Statistical System Committee (ESS Committee),
Ukrepi, predvideni s tem sklepom, so v skladu z mnenjem Odbora za evropski statistični sistem (Odbor ESS) –
The Annex to Decision 2004/452/EC is replaced by the text set out in the Annex to this Decision.
Priloga k Odločbi 2004/452/ES se nadomesti z besedilom iz Priloge k temu sklepu.
Employment Analysis Unit, Directorate General for Employment, Social Affairs and Equal Opportunities of the European Commission
Oddelek za analizo politike zaposlovanja, Generalni direktorat za zaposlovanje, socialne zadeve in enake možnosti Evropske komisije
Tel Aviv University (Israel)
University of Tel Aviv (Izrael)
Econometrics and Statistical Support to Antifraud (ESAF) Unit, Joint Research Centre of the European Commission
Enota „Ekonometrija in statistična podpora boju proti goljufijam (ESAF)“ Generalni direktorat Evropske komisije Skupno raziskovalno središče
Support to the European Research Area (SERA) Unit, Joint Research Centre of the European Commission
Enota „Podpora evropskemu raziskovalnemu prostoru (SERA)“ Generalni direktorat Evropske komisije Skupno raziskovalno središče
Directorate for Research, Studies and Statistics (Direction de l’Animation de la Recherche, des Études et des Statistiques – DARES) in the Ministry of Labour, Labour Relations and Solidarity, Paris, France
Direktorat za raziskave, študije in statistiko (Direction de l’Animation de la Recherche, des Études et des Statistiques – DARES) pri ministrstvu za delo, delovna razmerja in solidarnost, Pariz, Francija
Directorate for Research, Studies, Assessment, and Statistics (Direction de la Recherche, des Études, de l’Évaluation et des Statistiques – DREES) in the Ministry of Labour, social dialogue and solidarity, the Ministry of Health, youth and sports and the Ministry of Budget, public accounts and state reform, Paris, France
Direktorat za raziskave, študije, vrednotenje in statistiko (Direction de la Recherche, des Études, de l‘Évaluation et des statistiques – DREES) pri ministrstvu za delo, socialni dialog in solidarnost, ministrstvu za zdravje, mladino in šport ter ministrstvu za proračun, javne finance in državno reformo, Pariz, Francija
Federal Public Service Social Security, Belgium
Zvezni javni urad za socialno varnost, Belgija
Sabanci University, Tuzla/Istanbul, Turkey
Sabanci University, Tuzla/Istanbul, Turčija
Directorate Economic Service and Structural Reforms, Directorate General for Economic and Financial Affairs of the European Commission’
Direktorat Gospodarska služba in strukturne reforme Generalnega direktorata za gospodarske in finančne zadeve Evropske komisije“
on the allocation of quantities of controlled substances other than hydrochlorofluorocarbons allowed for essential or critical laboratory and analytical uses in the Union in 2010 under Regulation (EC) No 1005/2009 of the European Parliament and of the Council on substances that deplete the ozone layer
o dodelitvi količin nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki in so dovoljene za laboratorijske in analitske uporabe bistvenega ali nujnega pomena v Uniji v letu 2010 v skladu z Uredbo (ES) št. 1005/2009 Evropskega parlamenta in Sveta o snoveh, ki tanjšajo ozonski plašč
(notified under document C(2010) 3850)
(notificirano pod dokumentarno številko C(2010) 3850)
(Only the Dutch, English, Estonian, French, German, Italian and Spanish texts are authentic)
(besedilo v angleškem, estonskem, francoskem, italijanskem, nemškem, nizozemskem in španskem jeziku je edino verodostojno)
Having regard to Regulation (EC) No 1005/2009 of the European Parliament and of the Council of 16 September 2009 on substances that deplete the ozone layer [1], and in particular Article 10(2) thereof,
ob upoštevanju Uredbe (ES) št. 1005/2009 Evropskega parlamenta in Sveta z dne 16. septembra 2009 o snoveh, ki tanjšajo ozonski plašč [1], in zlasti člena 10(2) Uredbe,
The Union has already phased out the production and consumption of chlorofluorocarbons, other fully halogenated chlorofluorocarbons, halons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane for most uses.
Unija je že postopno opustila proizvodnjo in porabo klorofluoroogljikovodikov, drugih popolnoma halogeniranih klorofluoroogljikovodikov, halonov, ogljikovega tetraklorida, 1,1,1-trikloroetana, delno halogeniranih bromofluoroogljikovodikov in bromoklorometana.
The Commission is required to determine essential laboratory and analytical uses for these controlled substances, the quantities that may be used and the companies that may use them.
Komisija mora določiti laboratorijske in analitske uporabe bistvenega pomena za te nadzorovane snovi, količine, ki se smejo uporabljati, ter gospodarske družbe, ki jih smejo uporabljati.
Decision XIX/18 of the Parties to the Montreal Protocol authorises the production and consumption necessary to satisfy essential laboratory and analytical uses of controlled substances listed in Annexes A, B and C (Group II and III substances) of the Montreal Protocol as listed in Annex IV to the report of the Seventh Meeting of the Parties, subject to the conditions set out in Annex II to the report of the Sixth Meeting of the Parties, as well as Decisions VI/9, VII/11, XI/15 XV/5, XVI/16 and XXI/16 of the Parties to the Montreal Protocol.
V sklepu XIX/18 pogodbenic Montrealskega protokola je odobren obseg proizvodnje in porabe nadzorovanih snovi, naštetih v Prilogah A, B in C (snovi v skupinah II in III) k Montrealskem protokolu, ki je potreben za uporabe bistvenega pomena za laboratorijske in analitske namene v skladu s Prilogo IV k Poročilu o sedmem zasedanju pogodbenic, ob upoštevanju pogojev, opredeljenih v Prilogi II k Poročilu o šestem zasedanju pogodbenic ter sklepov VI/9, VII/11, XI/15, XV/5, XVI/16 in XXI/16 pogodbenic Montrealskega protokola.
Decision XVII/10 of the Parties to the Montreal Protocol authorises the production and consumption of methyl bromide, listed in Annex E of the Montreal Protocol, necessary to satisfy laboratory and analytical critical uses of methyl bromide.
V Sklepu XVII/10 pogodbenic Montrealskega protokola je odobren obseg proizvodnje in porabe metil bromida, naštetih v Prilogi E k Montrealskemu protokolu, ki je potreben za nujne laboratorijske in analitske uporabe metil bromida.
Under the Montreal Protocol global laboratory and analytical-use exemption is subject to periodic review and has last been extended by Decision XXI/6 until 31 December 2014.
Splošno izvzetje iz laboratorijske in analitske uporabe se na podlagi Montrealskega protokola redno preverja in je bilo nazadnje s Sklepom XXI/6 podaljšano do 31. decembra 2014.
Decision VI/25 specifies that a use can only be considered as essential if there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.
Sklep VI/25 določa, da se določena uporaba lahko šteje kot bistvenega pomena samo, če ni tehnično ali ekonomsko izvedljivih drugih možnosti ali nadomestkov, ki bi bili sprejemljivi s stališča okolja in zdravja.
An Annex listing those uses for which the Parties of the Montreal Protocol consider alternatives to be available should be established.
Izdelati je treba prilogo s seznamom tistih vrst uporabe, pri katerih pogodbenice Montrealskega protokola menijo, da so na voljo druge možnosti.
This Annex should also contain the positive list of permitted essential uses of methyl bromide, as agreed by the Parties in Decision XVIII/15.
Ta priloga mora vsebovati tudi pozitivni seznam dovoljenih uporab metil bromida za bistvene namene, o katerem so se pogodbenice dogovorile s Sklepom XVIII/15.
The Commission has published a notice to undertakings intending to import or export controlled substances that deplete the ozone layer to or from the European Union in 2010 and undertakings intending to request for 2010 a quota for these substances intended for laboratory and analytical uses [2] and has received declarations on intended essential laboratory and analytical uses of controlled substances for 2009.
Komisija je objavila Obvestilo podjetjem, ki nameravajo leta 2010 v Evropsko unijo uvažati ali izvažati iz nje nadzorovane snovi, ki tanjšajo ozonski plašč, in podjetjem, ki nameravajo za leto 2010 zaprositi za kvoto za te snovi, namenjene laboratorijski in analitski uporabi [2], ter tako prejela izjave o nameravanih laboratorijskih in analitskih uporabah nadzorovanih snovi za bistvene namene v letu 2009.
The measures provided for in this Decision are in accordance with the opinion of the Management Committee established by Article 25(1) of Regulation (EC) No 1005/2009,
Ukrepi, predvideni s tem sklepom, so v skladu z mnenjem upravljalnega odbora, ustanovljenega s členom 25(1) Uredbe (ES) št. 1005/2009 –
The production and import of controlled substances other than hydrochlorofluorocarbons may be permitted for any essential laboratory and analytical use specified in Annex I.
Proizvodnja in uvoz nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki, sta dovoljena za vse bistvene laboratorijske in analitske uporabe, kot je določeno v Prilogi I.
The quantity of controlled substances other than hydrochlorofluorocarbons subject to Regulation (EC) No 1005/2009 which may be produced or imported for essential laboratory and analytical uses in the Union in 2010 shall be 63843,371 ODP kilograms.
Količina nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki, v skladu z Uredbo (ES) št. 1005/2009, ki se sme proizvajati ali uvažati za bistvene laboratorijske in analitske uporabe v Uniji v letu 2010, je 63843,371 kilograma ODP.
The allocation of essential laboratory and analytical use quotas for controlled substances other than hydrochlorofluorocarbons for the year 2010 shall be to the undertakings indicated in Annex II.
Kvote za bistvene laboratorijske in analitske uporabe nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki, se za leto 2010 dodeli podjetjem v Prilogi II.
The maximum quantities that may be produced or imported in 2010 for laboratory and analytical uses allocated to these undertakings shall be set out in Annex III.
Največje količine, ki so dodeljene tem podjetjem in se lahko v letu 2010 proizvedejo ali uvozijo za laboratorijske in analitske uporabe, so navedene v Prilogi III.
Essential laboratory and analytical uses of controlled substances other than hydrochlorofluorocarbons
Laboratorijske in analitske uporabe bistvenega pomena nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki
Controlled substances of Group I (chlorofluorocarbons 11, 12, 113, 114 and 115), Group II (other fully halogenated chlorofluorocarbons), Group III (halons), Group IV (carbon tetrachloride), Group V (1,1,1-trichloroethane), Group VII (hydrobromofluorocarbons) and Group IX (bromochloromethane) may be permitted for all laboratory and analytical uses with the exception of the following:
Nadzorovane snovi skupine I (klorofluoroogljikovodiki 11, 12, 113, 114 in 115), skupine II (drugi popolnoma halogenirani klorofluoroogljikovodiki), skupine III (haloni), skupine IV (ogljikov tetraklorid), skupine V (1,1,1-trikloroetan), skupine VII (bromofluoroogljikovodiki) in skupine IX (bromoklorometan) so dovoljene za vse laboratorijske in analitske uporabe, z izjemo naslednjega:
testing of oil, grease and total petroleum hydrocarbons in water;
določanja olja, maščobe in ogljikovodikov iz mineralnih olj v vodi;
testing of tar in road-paving materials;
določanja katrana v materialih za polaganje cest;
forensic finger-printing;
forenzičnega odvzemanja prstnih odtisov;
testing of organic matter in coal;
določanja organske snovi v premogu;
any use for which a technically and economically feasible alternative is available.
kakršne koli uporabe, za katero je na voljo tehnično in ekonomsko izvedljiva druga možnost.
Methyl bromide (Group VI) may be permitted for the following essential laboratory and analytical uses:
Metil bromid (skupina VI) je dovoljen za naslednje bistvene laboratorijske in analitske uporabe:
as a reference or standard to calibrate equipment which uses methyl bromide, to monitor methyl bromide emission levels or to determine methyl bromide residue levels in goods, plants and commodities;
kot referenca ali standard za kalibriranje opreme, pri kateri se uporablja metil bromid, za spremljanje ravni izpustov metil bromida ali za določanje ostankov metil bromida v blagu, rastlinah in bazičnih proizvodih;
in laboratory toxicological studies;
v laboratorijskih toksikoloških študijah;
to compare the efficacy of methyl bromide and its alternatives inside a laboratory;
za primerjavo učinkovitosti metil bromida in nadomestnih snovi zanj znotraj laboratorija;
as a laboratory agent which is destroyed in a chemical reaction in the manner of feedstock.
kot laboratorijska pomožna snov, ki se kot surovina uniči v kemijski reakciji.
Following uses are not considered as essential laboratory and analytical uses:
Naslednje uporabe se ne štejejo kot bistvene laboratorijske in analitske uporabe:
refrigeration and air-conditioning equipment used in laboratories, including refrigerated laboratory equipment such as ultra-centrifuges;
hladilne in klimatske naprave v laboratorijih, vključno s hlajeno laboratorijsko opremo, kot so ultracentrifuge;
cleaning, reworking, repair, or rebuilding of electronic components or assemblies;
čiščenje, preoblikovanje, popravilo ali prenova elektronskih komponent sklopov;
preservation of publications and archives;
ohranjanje publikacij in arhivov;
sterilisation of materials in a laboratory.
sterilizacija materialov v laboratoriju.
Undertakings entitled to produce or import for essential laboratory and analytical uses
Podjetja, ki so upravičena do proizvodnje ali uvoza za bistvene laboratorijske in analitske uporabe
Quota entitling to produce or import controlled substances other than hydrochlorofluorocarbons, which may be used for essential laboratory and analytical uses, are allocated to:
Kvote za dovoljeno proizvodnjo ali uvoz nadzorovanih snovi, ki niso delno halogenirani klorofluoroogljikovodiki in se lahko uporabijo za bistvene laboratorijske in analitske namene, se dodelijo naslednjim podjetjem:
on the safety requirements to be met by European standards for certain products in the sleep environment of children pursuant to Directive 2001/95/EC of the European Parliament and of the Council
o varnostnih zahtevah, ki jim morajo ustrezati Evropski standardi za nekatere proizvode v spalnem okolju otrok, v skladu z Direktivo 2001/95/ES Evropskega parlamenta in Sveta
Having regard to Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety [1], and in particular Article 4(1)(a) thereof,
ob upoštevanju Direktive 2001/95/ES Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov [1] in zlasti člena 4(1)(a) Direktive,
Under Directive 2001/95/EC a product is presumed safe, as far as the risks and risk categories covered by national standards are concerned, when it complies with voluntary national standards transposing European standards.
V skladu z Direktivo 2001/95/ES se domneva, da je proizvod varen glede nevarnosti in vrst nevarnosti, zajetih v ustreznih nacionalnih standardih, kadar je v skladu s prostovoljnimi nacionalnimi standardi, ki prevzemajo evropske.
For these products, the study compiled statistics on accidents and injuries in the Union and worldwide and carried out a complete risk assessment, based on an identification of the main hazards and an assessment of exposure scenarios.
V okviru študije so bili za te proizvode zbrani statistični podatki o nesrečah in poškodbah v Uniji in po svetu, opravljena pa je bila tudi celovita ocena tveganja, ki je temeljila na opredelitvi glavnih nevarnosti in oceni možnih izpostavljenosti.
Five types of products assessed by the study, which are regularly found in the sleep environment of newborns and young children, were identified for follow-up to the study.
Za pet vrst proizvodov, ki so bili ocenjeni v študiji in se pogosto nahajajo v spalnem okolju novorojenčkov in majhnih otrok, je bilo določeno spremljanje po zaključku študije.
These are cot mattresses, cot bumpers, suspended baby beds, children’s duvets and children’s sleep bags.
Ti proizvodi so posteljni vložki za otroške posteljice, ščitniki za otroške posteljice, viseče posteljice za dojenčke, prešite odeje za otroke in spalne vreče za otroke.
Every day, newborns sleep for on average at least 16 hours, and at 3-5 years children still sleep for 11-13 hours a day.
Novorojenčki spijo povprečno 16 ur na dan, otroci, stari od 3 do 5 let, pa še vedno spijo 11–13 ur na dan.
Including awake periods, babies and young children spend at least half of the day in a sleep environment during their first five years of life.
Dojenčki in majhni otroci v prvih petih letih življenja, vključno z budnimi obdobji, preživijo vsaj polovico dneva ali več v svojem spalnem okolju.